Gyeongsangnam, South Korea

Amicogen, Inc.

Calculating rank
USPTO Granted Patents = 4


Trademarks = 1

Forward Citations = 0

Loading Chart...
Loading Chart...

22 inventors (with patents filed for the assignee):

goldMedal Zhe Piao (2 out of 2 patents)

silverMedal Nahm Ryune Cho (1 out of 8 patents)

bronzeMedal Su-Lim Choi (1 out of 1 patent)

4.  Yang Ho Jo (1 out of 1 patent)

5.  So-Young Park (1 out of 1 patent)

6.  Dae Beom Kwon (1 out of 1 patent)

7.  Yong Chul Shin (1 out of 4 patents)

8.  Si-Hyoung Lee (1 out of 1 patent)

9.  Yong-Chul Shin (1 out of 1 patent)

10.  Yeong-Joong Jeon (1 out of 1 patent)

11.  Kyung-Hwa Jung (1 out of 1 patent)

12.  Eun-Jung Ryu (1 out of 1 patent)

13.  Ko-Woon Lee (1 out of 1 patent)

14.  Jong Keun Kim (1 out of 3 patents)

15.  Min Soo Park (1 out of 34 patents)


4 patents:

Company Overview
Amicogen, Inc. is a biotech company that specializes in the development and production of high-quality bioactive compounds. With a focus on research and innovation, Amicogen aims to improve human health and well-being through its cutting-edge biotechnology solutions. The company is committed to sustainable practices and is dedicated to providing customers with top-notch products that meet the highest standards of quality and safety.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

4 Patents

#8 in Gyeongsangnam

#2,203 in South Korea

Gyeongsangnam, KR
Gyeongsangnam, South Korea
Forward Citations = 0

22 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amicogen, Inc.. Retrieved from https://idiyas.com/company/amicogen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…